CONDITIONS TREATeD / ANTI AGING
Regenerate. Repair. Restore.
Stem Cells Therapy for Anti-Aging
WHAT IS STEM CELL THERAPY?
HOW STEM CELL THERAPY WILL HELP?
WHAT SETS US APART?
WHY STEM CELLS TRANSPLANT INSTITUTE?
Using your own stem cells can delay the ageing process and improve the quality of life by repairing damaged tissue and regenerating healthy tissue.
Stem cell treatment, at the Stem Cells Transplant Institute, promotes self-healing and can help delay the signs and symptoms of ageing. Men and women treated at the Stem Cells Transplant Institute have reported:
- Increased energy levels and physical activity
Improved memory and focus - Reduced appearance of wrinkles and age spots
- Increased sex drive
- Improved lab values
- Improved lab values
- Decreased blood sugar levels
- Improved lipid profile
- Decreased creatinine
- Decreased C reactive protein (marker of inflammation)
What do we know about aging?
Your body is made up of millions and millions of cells. As you become older, your cells lose the ability to regenerate and repair themselves, causing changes in your body.
The skin becomes thinner and loses its elasticity, causing wrinkles. Bones weaken as they become thinner.
As the brain cells die, you begin to lose focus and your memory deteriorates. Scientists are not sure about the exact cause of ageing, but they do know that the more harmful molecules we are expose to, the more damage we accumulate, and the quicker we age.
The following are some of the harmful molecules:
- Glucose
- Cigarette smoke
- Environmental pollution
- Pesticides
- Ozone
As your immune system weakens, it releases signals that increase inflammation. Physicians can measure inflammation to help predict disease and disability. Controlling inflammation can slow or prevent the progression of diseases and disabilities.
What is the recommended treatment protocol for Anti-Aging at the Stem Cells Transplant Institute?
For anti-aging treatments, we recommend using your own body’s natural healing agents to repair and reverse the signs of aging.
At the Stem Cells Transplant Institute, we recommend using autologous mesenchymal stem cells for the treatment of ageing.
We use two types of mesenchymal stem cells for anti-ageing treatments: adipose tissue-derived stem cells and bone marrow-derived stem cells.
Mesenchymal stem cells derived from adipose tissue are immunosuppressive and can differentiate into a variety of cell types, including osteocytes, adipocytes, neural cells, vascular endothelial cells, and others, making them ideal for anti-aging treatments.
Mesenchymal stem cells derived from your own bone marrow are ideal for repairing bone, cartilage, muscle, tendons, and ligaments.
We recommend a one-day treatment using both adipose and bone marrow derived stem cells for anti-aging.
Treatment at the Stem Cells Transplant Institute may help you feel more active and youthful again by reducing the signs and symptoms of ageing.
Can stem cell therapy improve the signs and symptoms of aging?
Although no one can live forever, but stem cell therapy can help slow and even repair the signs of ageing.
Mesenchymal stem cells modulate the immune system, reduce inflammation and repair damaged tissue.
The anti-aging experts at the Stem Cells Transplant Institute take your stem cells from adipose tissue and bone marrow, activate those stem cell, and then give them back to you intravenously and by injection into the areas that show signs of ageing such as your face and hands.
Stem cells obtained from adipose tissue and bone marrow were found to be more stable than other cells and perform better at cell adhesion, migration and wound healing.
Organs such as the skin, brain, heart, liver, joints and kidney benefit from activated mesenchymal stem cells because they heal damage and improve their functions.
UMBILICAL CORD DONATIONS
How Are the Stem Cells Collected?
Our clinic focuses on obtaining healthy stem cells exclusively from umbilical cord blood donors. We collect the placenta once the baby is born, with the parent’s informed consent. Additionally, we follow strict ethical guidelines and collect stem cells from reliable and reputable sources.
INTRAVENUS ADMINISTRATION
How Are the Stem Cells Administered?
Our nursing staff administers the stem cells through an intravenous and intra-pulmonary route. For the most effective outcomes, intravenous administration is preferred.
About the Stem Cells Transplant Institute
Our clinic is located in Costa Rica, which is one of the most popular medical tourism destinations for stem cell therapy. At the Stem Cells Transplant Institute, we have a skilled team of doctors and medical professionals who collect and administer stem cells to treat autism and other conditions. Every patient receives the most cost-effective and top-notch care from our dedicated team.
Please fill this form
Scientific References:
- Fu et al. Stem cell transplantation therapy in Parkinson’s disease. SpringerPlus (2015) 4:597
- Joyce et al. Mesenchymal stem cell for the treatment of neurodegenerative disease. Regen Med. 2010, November, 5(6)933-946. Doi:10.2217/rme.10.72
- Helena Vilaça-Faria, António J. Salgado and Fábio G.
- Teixeira Mesenchymal Stem Cells-derived Exosomes: A New Possible Therapeutic Strategy for Parkinson’s disease. Cells2019, 8(2), 118; doi:3390/cells8020118
Teixeira, F.G.; Carvalho, M.M.; Neves-Carvalho, A.; Panchalingam, K.M.; Behie, L.A.; Pinto, L.; Sousa, N.; Salgado, A.J. Secretome of mesenchymal progenitors from the umbilical cord acts as modulator of neural/glial proliferation and differentiation. Stem Cell Rev.2015, 11, 288–297. [Google Scholar] [CrossRef] [PubMed] - Gao, F.; Chiu, S.M.; Motan, D.A.; Zhang, Z.; Chen, L.; Ji, H.L.; Tse, H.F.; Fu, Q.L.; Lian, Q. Mesenchymal stem cells and immunomodulation: current status and future prospects. Cell Death Dis.2016, 7, e2062. [Google Scholar] [CrossRef] [PubMed]
- Joyce, N.; Annett, G.; Wirthlin, L.; Olson, S.; Bauer, G.; Nolta, J.A. Mesenchymal stem cells for the treatment of neurodegenerative disease. Med.2010, 5, 933–946. [Google Scholar] [CrossRef] [PubMed]
- Fraga, J.S.; Silva, N.A.; Lourenco, A.S.; Goncalves, V.; Neves, N.M.; Reis, R.L.; Rodrigues, A.J.; Manadas, B.; Sousa, N.; Salgado, A.J. Unveiling the effects of the secretome of mesenchymal progenitors from the umbilical cord in different neuronal cell populations. Biochimie2013, 95, 2297–2303. [Google Scholar] [CrossRef] [PubMed]
- Ribeiro, C.A.; Fraga, J.S.; Graos, M.; Neves, N.M.; Reis, R.L.; Gimble, J.M.; Sousa, N.; Salgado, A.J. The secretome of stem cells isolated from the adipose tissue and Wharton jelly acts differently on central nervous system derived cell populations. Stem Cell Res. Ther.2012, 3, 18. [Google Scholar] [CrossRef]
- Ribeiro, C.A.; Salgado, A.J.; Fraga, J.S.; Silva, N.A.; Reis, R.L.; Sousa, N. The secretome of bone marrow mesenchymal stem cells-conditioned media varies with time and drives a distinct effect on mature neurons and glial cells (primary cultures). Tissue Eng. Regen. Med.2011, 5, 668–672. [Google Scholar] [CrossRef]
- Salgado, A.J.; Fraga, J.S.; Mesquita, A.R.; Neves, N.M.; Reis, R.L.; Sousa, N. Role of human umbilical cord mesenchymal progenitors conditioned media in neuronal/glial cell densities, viability, and proliferation. Stem Cells Dev.2010, 19, 1067–1074. [Google Scholar] [CrossRef]
- Martins, L.F.; Costa, R.O.; Pedro, J.R.; Aguiar, P.; Serra, S.C.; Teixeira, F.G.; Sousa, N.; Salgado, A.J.; Almeida, R.D. Mesenchymal stem cells secretome-induced axonal outgrowth is mediated by BDNF. Rep.2017, 7, 4153. [Google Scholar] [CrossRef]
- Serra, S.C.; Costa, J.C.; Assuncao-Silva, R.C.; Teixeira, F.G.; Silva, N.A.; Anjo, S.I.; Manadas, B.; Gimble, J.M.; Behie, L.A.; Salgado, A.J. Influence of passage number on the impact of the secretome of adipose tissue stem cells on neural survival, neurodifferentiation and axonal growth. Biochimie2018, 155, 119–128. [Google Scholar] [CrossRef]
- Assuncao-Silva, R.C.; Mendes-Pinheiro, B.; Patricio, P.; Behie, L.A.; Teixeira, F.G.; Pinto, L.; Salgado, A.J. Exploiting the impact of the secretome of MSCs isolated from different tissue sources on neuronal differentiation and axonal growth. Biochimie2018, 155, 83–91. [Google Scholar] [CrossRef] [PubMed]
